You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050420

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 050420 describes RIFADIN, which is a drug marketed by Sanofi Aventis Us and is included in three NDAs. It is available from one supplier. Additional details are available on the RIFADIN profile page.

The generic ingredient in RIFADIN is rifampin. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Summary for 050420
Applicant:Sanofi Aventis Us
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 050420
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIFADIN rifampin CAPSULE;ORAL 050420 NDA Sanofi-Aventis U.S. LLC 0068-0508 0068-0508-60 60 CAPSULE in 1 BOTTLE (0068-0508-60)
RIFADIN rifampin CAPSULE;ORAL 050420 NDA Sanofi-Aventis U.S. LLC 0068-0510 0068-0510-30 30 CAPSULE in 1 BOTTLE (0068-0510-30)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.